Pacira Pharmaceuticals buy HC Wainwright
Start price
02.07.24
/
50%
€21.20
Target price
02.07.25
€53.05
Performance (%)
-15.57%
Price
19.07.24
€18.00
Summary
This prediction is currently active. The price of Pacira Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -15.57%. This prediction currently runs until 02.07.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Pacira Pharmaceuticals | -9.091% |
iShares Core DAX® | -3.033% |
iShares Nasdaq 100 | -3.554% |
iShares Nikkei 225® | -3.938% |
iShares S&P 500 | -1.517% |
Comments by HC_Wainwright for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $57.00 price target on the stock.
Ratings data for PCRX provided by MarketBeat
Stopped prediction by HC_Wainwright for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.80
08.05.24
08.05.24
€53.04
08.05.25
08.05.25
-33.21%
19.07.24
19.07.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.20
04.03.24
04.03.24
€52.53
04.03.25
04.03.25
-30.15%
19.07.24
19.07.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€28.40
06.11.23
06.11.23
€53.07
06.11.24
06.11.24
-36.97%
19.07.24
19.07.24